WOOJUNG BIO Statistics

Total Valuation

WOOJUNG BIO has a market cap or net worth of KRW 24.86 billion. The enterprise value is 71.39 billion.

Market Cap	24.86B
Enterprise Value	71.39B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

WOOJUNG BIO has 16.83 million shares outstanding. The number of shares has increased by 17.40% in one year.

Current Share Class	n/a
Shares Outstanding	16.83M
Shares Change (YoY)	+17.40%
Shares Change (QoQ)	+16.38%
Owned by Insiders (%)	33.34%
Owned by Institutions (%)	3.65%
Float	10.27M

Valuation Ratios

The trailing PE ratio is 98.47.

PE Ratio	98.47
Forward PE	n/a
PS Ratio	0.51
PB Ratio	0.89
P/TBV Ratio	0.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.93, with an EV/FCF ratio of -50.32.

EV / Earnings	316.89
EV / Sales	1.65
EV / EBITDA	11.93
EV / EBIT	40.07
EV / FCF	-50.32

Financial Position

The company has a current ratio of 0.64, with a Debt / Equity ratio of 1.74.

Current Ratio	0.64
Quick Ratio	0.33
Debt / Equity	1.74
Debt / EBITDA	8.52
Debt / FCF	-35.93
Interest Coverage	0.55

Financial Efficiency

Return on equity (ROE) is 0.88% and return on invested capital (ROIC) is 1.44%.

Return on Equity (ROE)	0.88%
Return on Assets (ROA)	1.16%
Return on Invested Capital (ROIC)	1.44%
Return on Capital Employed (ROCE)	2.82%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.45
Inventory Turnover	6.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.81% in the last 52 weeks. The beta is 0.77, so WOOJUNG BIO's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-20.81%
50-Day Moving Average	1,627.74
200-Day Moving Average	1,785.28
Relative Strength Index (RSI)	34.87
Average Volume (20 Days)	39,698

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WOOJUNG BIO had revenue of KRW 43.20 billion and earned 225.30 million in profits. Earnings per share was 15.00.

Revenue	43.20B
Gross Profit	12.59B
Operating Income	1.78B
Pretax Income	225.30M
Net Income	225.30M
EBITDA	5.99B
EBIT	1.78B
Earnings Per Share (EPS)	15.00

Full Income Statement

Balance Sheet

The company has 4.45 billion in cash and 50.98 billion in debt, giving a net cash position of -46.54 billion or -2,765.19 per share.

Cash & Cash Equivalents	4.45B
Total Debt	50.98B
Net Cash	-46.54B
Net Cash Per Share	-2,765.19
Equity (Book Value)	29.37B
Book Value Per Share	1,660.37
Working Capital	-11.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.13 billion and capital expenditures -292.45 million, giving a free cash flow of -1.42 billion.

Operating Cash Flow	-1.13B
Capital Expenditures	-292.45M
Free Cash Flow	-1.42B
FCF Per Share	-84.31

Full Cash Flow Statement

Margins

Gross margin is 29.14%, with operating and profit margins of 4.13% and 0.52%.

Gross Margin	29.14%
Operating Margin	4.13%
Pretax Margin	0.52%
Profit Margin	0.52%
EBITDA Margin	13.86%
EBIT Margin	4.13%
FCF Margin	n/a

Dividends & Yields

WOOJUNG BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.40%
Shareholder Yield	-17.40%
Earnings Yield	0.91%
FCF Yield	-5.71%

Stock Splits

The last stock split was on July 30, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jul 30, 2019
Split Type	Forward
Split Ratio	2

Scores

WOOJUNG BIO has an Altman Z-Score of 0.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.25
Piotroski F-Score	n/a